FDA Proposes Regulations for AI-Powered Medical Devices
Because AI retrains itself over time, the administration wants to keep tabs on what’s happening under the hood.
By
The Food and Drug Administration is trying to figure out how to regulate artificial intelligence as the medical community starts experimenting with the tech.
The FDA on Tuesday proposed a first-of-its-kind framework for assessing the safety and effectiveness of medical devices that rely on AI and machine learning. While doctors have long evangelized AI’s potential to improve healthcare and advance research, the tech presents a handful of issues the administration has yet to fully grapple with.
The framework is currently open for public comment.
AI and ML “have the potential to transform healthcare by deriving new and important insights from the vast amount of data generated during the delivery of healthcare every day,” leading to earlier disease detection, more accurate diagnoses and personalized patient treatment, FDA officials wrote in the solicitation.
One of the tech’s greatest assets is its ability to learn from real-world use and experience—but that also makes it more difficult to regulate. A system’s performance could change as it retrains itself with new data, so it’s important for both regulators and manufacturers to monitor what’s happening under the hood, according to the FDA.
And because the field is developing so quickly, manufacturers should also have the ability to safely upgrade their devices without going back through the certification process every time.
“The highly iterative, autonomous and adaptive nature of these tools requires a new, total product lifecycle regulatory approach that facilitates a rapid cycle of product improvement … while providing effective safeguards,” officials wrote.
The framework would allow manufacturers to get potential future software changes preapproved by the FDA before their product ever goes to market, meaning they can upgrade the tool within those parameters without additional certifications. If they want to change algorithms or data inputs that go beyond those approved, they would need FDA certification.
Groups would also need to go back through the administration’s review process if they wanted to change how their product is used, say, from detecting diseases to diagnosing patients.
Companies would be required to continuously monitor the accuracy and performance of the tech as it’s used in the field and regularly update FDA officials on software changes, even if they were preapproved.
“Transparency about the function and modifications of medical devices is a key aspect of their safety,” FDA said. “Gathering performance data on the real-world use of the [device] may allow manufacturers to understand how their products are being used, identify opportunities for improvements and respond proactively to safety or usability concerns.”
*********
(TLB) published this article from NextGov.com with our sincere appreciation for it’s availability to share.
••••
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
••••
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
••••
Disclaimer: The Liberty Beacon contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Leave a Reply